MDBH (MDB Capital Holdings, LLC Class A common) Stock Analysis - News
MDB Capital Holdings, LLC Class A common (MDBH) is a publicly traded Financial Services sector company. As of May 20, 2026, MDBH trades at $3.68 with a market cap of $33.37M and a P/E ratio of 0.00. MDBH moved +0.00% today. Year to date, MDBH is +10.00%; over the trailing twelve months it is -12.60%. Its 52-week range spans $2.75 to $9.42. Rallies surfaces MDBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in MDBH news today?
PatentVest Debuts Case Studies Section Highlighting AI Patent Strategy with Docana: PatentVest launched a new Case Studies section on its website, featuring an engagement with AI company Docana to navigate the LLM patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP decision-making. The study outlines how PatentVest defined IP boundaries and trade-secret strategies for enterprise AI commercialization.
James Jeremy William sold 60 (~$200.4) on Jan 23, 2026.
MARLETT CHRISTOPHER A bought 1.21K (~$4.25K) on Jan 2, 2026.
MARLETT CHRISTOPHER A bought 4.39K (~$14.70K) on Dec 31, 2025.
MDBH Analyst Consensus
MDBH analyst coverage data. Average price target: $0.00.
Common questions about MDBH
What changed in MDBH news today?
PatentVest Debuts Case Studies Section Highlighting AI Patent Strategy with Docana: PatentVest launched a new Case Studies section on its website, featuring an engagement with AI company Docana to navigate the LLM patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP decision-making. The study outlines how PatentVest defined IP boundaries and trade-secret strategies for enterprise AI commercialization.
Does Rallies summarize MDBH news?
Yes. Rallies summarizes MDBH news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is MDBH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MDBH. It does not provide personalized investment advice.
